LDL胆固醇和心力衰竭的临床结果与减少喷射分数是竞争的风险分析
Qi Wang1, Zhiquan Liu1, Wenqing Zhou1
1Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.
Scientific reports
|November 20, 2025
概括
在心力衰竭患者中降低低密度脂蛋白胆固醇 (LDL-C) 的降低与死亡率的增加有关,而不是减少缺血事件. 需要进一步的研究来澄清降脂疗法在这个人群中的益处.
科学领域:
- 心脏病学 心脏病学
- 临床研究 临床研究
- 公共卫生 公共卫生
背景情况:
- 低密度脂蛋白胆固醇 (LDL-C) 是已知的动脉样硬化心血管疾病 (ASCVD) 的风险因素.
- 降低射出分数 (HFrEF) 的心力衰竭患者的LDL-C的预后意义尚未得到充分确立.
- 这项研究探讨了LDL-C在HFrEF结果中的有争议的作用.
研究的目的:
- 调查HFrEF患者的LDL-C基线水平与心血管事件或死亡率之间的关联.
- 根据心力衰竭的病因分析进行分层分析 (缺血性与非缺血性).
主要方法:
- 从HF-ACTION试验中分析了1,274名慢性稳定的HFrEF患者.
- 患者被分为低LDL-C (<100 mg/dL) 和高LDL-C (≥100 mg/dL) 的两组.
- 主要终点包括缺血性心血管事件和全因死亡率,使用Cox比例危险和Fine-Gray竞争风险模型进行分析.
主要成果:
- 较低的基线LDL-C (<100 mg/dL) 与较高的全因死亡风险显著相关 (调整HR=1.57).
- LDL-C水平与缺血性心血管事件没有显著关联.
- 亚组分析显示,LDL-C和心力衰竭病因之间没有显著的相互作用.
结论:
- 在慢性稳定的HFrEF中,较低的基线LDL-C与增加全因死亡率有关.
- 在这个队列中,较低的LDL-C水平与缺血事件风险降低无关.
- 在HFrEF中降脂疗法的净益需要通过表型特定试验进行进一步的研究.
更多相关视频
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
9.7K
07:24Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
24.7K
相关概念视频
01:26Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
01:30Heart Failure V: Medical Management
204
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
204
01:17Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
300
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
300
01:26Heart Failure III: Clinical Manifestations
452
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
452
01:27Heart Failure I: Introduction
671
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
671